Pharmaceutical Industry In China To 2020

Topics: Pharmacology, Pharmaceutical industry, Food and Drug Administration Pages: 21 (5321 words) Published: July 7, 2015
YRH: Pharmaceutical Industry in China to 2020 Market Overview, Size, Share, Analysis, Technology Developments, Development Status, Trends, Structure, Production Value and Forecast Research Report
Summary
“Pharmaceutical Industry in China to 2020: An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challengess” provides a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report is supported by over 265 tables & figures within 182 pages. The Chinese biopharmaceutical market is presented as follows: • By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS)

• By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression) A wealth of financial information is provided including:
• Company financials, sales & revenue figures
• China GDP, economic growth, export (bulk drug, formulations) figures • Indian health expenditure as a function of GDP
• Growth change figures of emerging and developing countries (India, Russia, China, Brazil) • Economic growth figures of advanced economies (USA, UK, Germany, France, Italy, Spain, Japan, Canada)
• Projected figures of strategic emerging industry GDP percentage contribution SWOT, Economic and Business Environment specifics include:
• Key strengths, weaknesses and threats influencing leading player position within the market
• Top Five Contract Pharmaceutical Export Markets of China • Major players within China’s leading therapeutic markets (e.g., cancer, allergy, liver disease) • Multinational penetration into the Chinese Pharma Market • Comprehensive product portfolios, R&D activity and pipeline therapeutics • M&A activity and future strategies of top Chinese pharmacos

• Economic indicators, trade policy, merchandise and commercial trade statistics • Gross Domestic Product of China, historic and projection analysis • Chinese economic outlook in comparison to advanced economies • Three Tier ‘Pharmerging’ Markets with Potential for Significant Growth • Prescription drug sales distribution channels in China

• Major biogeneric products in China
This report highlights a number of significant Chinese and multinational pharmacos and gives details of their operations, products, financials and business strategy. • Amoytop Biotech
• Active Pharmaceutical Products
• Beijing Continent Pharmaceuticals
• FusoGen Pharmaceuticals
• Shanghai Huaguan Biochip
• SiBiono GeneTech
• Abbott
• AstraZeneca
• Boehringer Ingelheim
• Eli Lilly
• GlaxoSmithKline
• Johnson & Johnson Medical
• Merck
• Novartis
• Pfizer
• Roche
Forecast projections and future growth rates are provided to give you a forthcoming perspective of this growing industry. Current developments relating to patent expirations, government funding, and regulations are discussed. The emerging trends that appear in key sub-markets such as generics, oncology, cardiovascular, diabetes and vaccines are elucidated and analysed.

What you will gain:
• An in-depth understanding of the Chinese biopharmaceutical market and it’s environment • Current market facts, figures and product lines of key players in the industry • An insight into how generic therapeutics will propagate the Chinese biopharmaceutical market

• Knowledge of how the Chinese pharma market will integrate into the global healthcare market
• Information on key regulatory and government policies
• Data on levels of private and publically funded biopharma studies in China • Strategies on how to adapt and restructure current business models to this industry This report tackles key concerns to the Chinese biopharmaceutical market such as: • Lack of regulatory policy and legislation

• Reimbursement schemes and payers concerns
•...
Continue Reading

Please join StudyMode to read the full document

You May Also Find These Documents Helpful

  • Pharmaceutical Industry Essay
  • Pharmaceutical Industry Essay
  • Pharmaceutical industry Essay
  • Pharmaceutical Industry Essay
  • Financial Analysis for Pharmaceutical Industry Essay
  • The Global Pharmaceutical Industry Essay
  • The Truth About Pharmaceutical Industry Essay
  • Competition in the UK's Pharmaceutical Industry Essay

Become a StudyMode Member

Sign Up - It's Free